Alimera Sciences Inc. (ALIM) announced the positive outcome of the Decentralized Procedure for ILUVIEN in Europe Tuesday morning.
Alimera Sciences gapped up sharply Tuesday morning and is now higher by 1.63 at $3.94, with trading volume already over a 3-month high. The stock has jumped to a 3 1/2 month high.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org